E. Maartense

3.3k total citations · 1 hit paper
49 papers, 2.0k citations indexed

About

E. Maartense is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Maartense has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 15 papers in Pathology and Forensic Medicine and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Maartense's work include Lymphoma Diagnosis and Treatment (10 papers), Breast Cancer Treatment Studies (9 papers) and Estrogen and related hormone effects (8 papers). E. Maartense is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Breast Cancer Treatment Studies (9 papers) and Estrogen and related hormone effects (8 papers). E. Maartense collaborates with scholars based in Netherlands, United States and United Kingdom. E. Maartense's co-authors include J.W.R. Nortier, P.M. Kluin, Felix E. de Jongh, Katja Philippo, Ed Schuuring, M Krámer, J. Han van Krieken, Daphne de Jong, Jos Hermans and Eric Geelen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

E. Maartense

48 papers receiving 1.9k citations

Hit Papers

Trastuzumab Beyond Progression in Human Epidermal Growth ... 2009 2026 2014 2020 2009 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study
    2009 504 citations Gϋnter von Minckwitz, Marcus Schmidt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Maartense Netherlands 17 1.3k 576 427 346 331 49 2.0k
H. Curé France 22 1.2k 0.9× 410 0.7× 327 0.8× 742 2.1× 118 0.4× 82 2.0k
Anne Floquet France 30 1.3k 1.0× 572 1.0× 758 1.8× 521 1.5× 85 0.3× 170 3.3k
Jolanda Schrama Netherlands 12 1.8k 1.4× 370 0.6× 667 1.6× 431 1.2× 114 0.3× 16 2.3k
Luigi Manzione Italy 29 2.4k 1.9× 267 0.5× 1.3k 3.0× 394 1.1× 92 0.3× 88 3.4k
Jean-Pierre Droz France 12 795 0.6× 103 0.2× 575 1.3× 144 0.4× 106 0.3× 12 2.0k
Lissandra Dal Lago Belgium 18 1.2k 0.9× 108 0.2× 254 0.6× 219 0.6× 124 0.4× 54 1.7k
Åke Berglund Sweden 26 2.0k 1.6× 285 0.5× 530 1.2× 215 0.6× 160 0.5× 53 2.6k
Jamey Skillings Canada 18 1.3k 1.0× 311 0.5× 514 1.2× 260 0.8× 149 0.5× 40 2.1k
Hans Wildiers Belgium 9 586 0.5× 151 0.3× 263 0.6× 257 0.7× 92 0.3× 33 1.1k
Denise K. Reinke United States 22 1.2k 0.9× 424 0.7× 1.7k 3.9× 231 0.7× 81 0.2× 54 2.8k

Countries citing papers authored by E. Maartense

Since Specialization
Citations

This map shows the geographic impact of E. Maartense's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Maartense with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Maartense more than expected).

Fields of papers citing papers by E. Maartense

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Maartense. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Maartense. The network helps show where E. Maartense may publish in the future.

Co-authorship network of co-authors of E. Maartense

This figure shows the co-authorship network connecting the top 25 collaborators of E. Maartense. A scholar is included among the top collaborators of E. Maartense based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Maartense. E. Maartense is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poel, Marjolein van der, Wubbo J. Mulder, G.J. Ossenkoppele, et al.. (2015). Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study. Annals of Hematology. 94(8). 1373–1379. 11 indexed citations
2.
Dezentjé, Vincent O., Frans L. Opdam, Hans Gelderblom, et al.. (2015). CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects. Breast Cancer Research and Treatment. 153(3). 583–590. 46 indexed citations
3.
Charehbili, Ayoub, Saskia van de Ven, Vincent T.H.B.M. Smit, et al.. (2014). Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01). Annals of Oncology. 25(5). 998–1004. 31 indexed citations
4.
Aaldriks, Ab A., Erik J. Giltay, Saskia le Cessie, et al.. (2013). Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy. The Breast. 22(5). 753–760. 61 indexed citations
5.
6.
Charehbili, Ayoub, Vincent T.H.B.M. Smit, Gerrit‐Jan Liefers, et al.. (2013). Abstract P1-08-19: Changes in circulating vitamin D levels as a predictor for pathological response to neoadjuvant chemotherapy (NAC) in breast cancer (BC): A Dutch breast cancer trialists group (BOOG) side-study. Cancer Research. 73(24_Supplement). P1–8. 1 indexed citations
7.
Hamaker, Marije E., Caroline Seynaeve, J.W.R. Nortier, et al.. (2013). Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study. The Breast. 22(4). 556–559. 12 indexed citations
8.
Minckwitz, Gϋnter von, Kathrin Schwedler, Marcus Schmidt, et al.. (2011). Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer. European Journal of Cancer. 47(15). 2273–2281. 141 indexed citations
9.
Aaldriks, Ab A., E. Maartense, Saskia le Cessie, et al.. (2010). Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Critical Reviews in Oncology/Hematology. 79(2). 205–212. 132 indexed citations
10.
Chaker, Layal, et al.. (2010). Haemophagocytic syndrome and Hodgkin’s disease variant of Richter’s syndrome after fludarabine for CLL. European Journal Of Haematology. 85(1). 91–92. 9 indexed citations
11.
Nes, Johanna G. H. van, Caroline Seynaeve, E. Maartense, et al.. (2009). Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial. Annals of Oncology. 21(5). 974–982. 7 indexed citations
12.
13.
Maartense, E., et al.. (2003). [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].. PubMed. 147(43). 2089–94. 3 indexed citations
14.
Maartense, E., Hanneke C. Kluin‐Nelemans, & E.M. Noordijk. (2003). Non-Hodgkin's lymphoma in the elderly. Annals of Hematology. 82(11). 661–670. 15 indexed citations
15.
Maartense, E., Saskia le Cessie, Hanneke C. Kluin‐Nelemans, et al.. (2002). Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin’slymphoma registry. Annals of Oncology. 13(8). 1275–1284. 21 indexed citations
16.
Jansen, S.J.T., J. Kievit, M. Nooij, et al.. (2001). Patients’ preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?. British Journal of Cancer. 84(12). 1577–1585. 73 indexed citations
17.
Maartense, E., Hanneke C. Kluin‐Nelemans, Saskia le Cessie, et al.. (2000). Different age limits for elderly patients with indolent and aggressive non-Hodgkin lymphoma and the role of relative survival with increasing age. Cancer. 89(12). 2667–2676. 35 indexed citations
18.
Maartense, E., J. Hermans, Hanneke C. Kluin‐Nelemans, et al.. (1998). Elderly patients with non-Hodgkin’s lymphoma: Population-based results in the Netherlands. Annals of Oncology. 9(11). 1219–1227. 45 indexed citations
19.
Jonge, N. De, et al.. (1995). High Plasma Antithrombin Levels in Acute Hepatitis A. Scandinavian Journal of Gastroenterology. 30(1). 95–96. 2 indexed citations
20.
Hart, William L. & E. Maartense. (1992). Hypothyroidism and chemodectoma in father and daughter: a new syndrome of a coincidence?. Clinical Endocrinology. 36(3). 295–296. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Curé Breakdown of academic impact, for papers by Anne Floquet Breakdown of academic impact, for papers by Jolanda Schrama Breakdown of academic impact, for papers by Luigi Manzione Breakdown of academic impact, for papers by Jean-Pierre Droz Breakdown of academic impact, for papers by Lissandra Dal Lago Breakdown of academic impact, for papers by Åke Berglund Breakdown of academic impact, for papers by Jamey Skillings Breakdown of academic impact, for papers by Hans Wildiers Breakdown of academic impact, for papers by Denise K. Reinke
Rankless by CCL
2026